Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21735901 | 0.93 | CHEK2 (0.31) | L3MBTL1CHEK2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL24772668 | 0.93 | CHEK2 (0.37) | L3MBTL1CHEK2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL21736151 | 0.91 | TDP1 (0.33) | TDP1L3MBTL1LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL20669988 | 0.91 | HCRTR1 (0.33) | L3MBTL1CHEK2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL21736293 | 0.90 | SMN1; SMN2 (0.38) | L3MBTL1CHEK2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL21735860 | 0.89 | TSHR (0.37) | L3MBTL1LMNASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL20670060 | 0.88 | SMN1; SMN2 (0.38) | L3MBTL1LMNASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL21735869 | 0.88 | TSHR (0.33) | LMNASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL21736039 | 0.87 | GRM4 (0.34) | ALDH1A1 | |
| SCHEMBL20670116 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | TDP1 2242/4885L3MBTL1 433/4885CHEK2 3750/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | TDP1 2242/4885L3MBTL1 433/4885CHEK2 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.